Roger E Thomas. J Pers Med 2020
Times Cited: 1
Times Cited: 1
List of co-cited articles
articles co-cited >1
Times Cited
Times Co-cited
Similarity
Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.
Petal A H M Wijnen, Marjolein Drent, Patty J Nelemans, Petra M J C Kuijpers, Ger H Koek, Cees Neef, Guido R M M Haenen, Otto Bekers. Drug Saf 2008
Petal A H M Wijnen, Marjolein Drent, Patty J Nelemans, Petra M J C Kuijpers, Ger H Koek, Cees Neef, Guido R M M Haenen, Otto Bekers. Drug Saf 2008
100
Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report of ten cases.
M I Liebhaber, R S Wright, H J Gelberg, Z Dyer, J L Kupperman. Chest 1999
M I Liebhaber, R S Wright, H J Gelberg, Z Dyer, J L Kupperman. Chest 1999
100
Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?
C Nordin, M L Dahl, M Eriksson, S Sjöberg. Lancet 1997
C Nordin, M L Dahl, M Eriksson, S Sjöberg. Lancet 1997
100
Clinical implications of pharmacogenetic variation on the effects of statins.
Simran D S Maggo, Martin A Kennedy, David W J Clark. Drug Saf 2011
Simran D S Maggo, Martin A Kennedy, David W J Clark. Drug Saf 2011
100
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
C Sachse, J Brockmöller, S Bauer, I Roots. Am J Hum Genet 1997
C Sachse, J Brockmöller, S Bauer, I Roots. Am J Hum Genet 1997
100
Managing the underestimated risk of statin-associated myopathy.
Loukianos S Rallidis, Katerina Fountoulaki, Maria Anastasiou-Nana. Int J Cardiol 2012
Loukianos S Rallidis, Katerina Fountoulaki, Maria Anastasiou-Nana. Int J Cardiol 2012
100
Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors.
H Fujino, T Saito, Y Tsunenari, J Kojima, T Sakaeda. Xenobiotica 2004
H Fujino, T Saito, Y Tsunenari, J Kojima, T Sakaeda. Xenobiotica 2004
100
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
100
Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges.
Catriona Hippman, Corey Nislow. J Pers Med 2019
Catriona Hippman, Corey Nislow. J Pers Med 2019
100
Statin use and musculoskeletal pain among adults with and without arthritis.
Catherine Buettner, Matthew J Rippberger, Julie K Smith, Suzanne G Leveille, Roger B Davis, Murray A Mittleman. Am J Med 2012
Catherine Buettner, Matthew J Rippberger, Julie K Smith, Suzanne G Leveille, Roger B Davis, Murray A Mittleman. Am J Med 2012
100
Pharmacogenomics of statins: understanding susceptibility to adverse effects.
Joseph P Kitzmiller, Eduard B Mikulik, Anees M Dauki, Chandrama Murkherjee, Jasmine A Luzum. Pharmgenomics Pers Med 2016
Joseph P Kitzmiller, Eduard B Mikulik, Anees M Dauki, Chandrama Murkherjee, Jasmine A Luzum. Pharmgenomics Pers Med 2016
100
Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin.
Piergiorgio Zuccaro, Giuliana Mombelli, Laura Calabresi, Damiano Baldassarre, Ilaria Palmi, Cesare R Sirtori. Pharmacol Res 2007
Piergiorgio Zuccaro, Giuliana Mombelli, Laura Calabresi, Damiano Baldassarre, Ilaria Palmi, Cesare R Sirtori. Pharmacol Res 2007
100
Hyperlipidaemia alone and in combination with acidosis can increase the incidence and severity of statin-induced myotoxicity.
Dhiaa A Taha, Atheer Zgair, Jong Bong Lee, Cornelia H de Moor, David A Barrett, Kimberley D Bruce, Mitchell Sungelo, Robert H Eckel, Pavel Gershkovich. Eur J Pharm Sci 2017
Dhiaa A Taha, Atheer Zgair, Jong Bong Lee, Cornelia H de Moor, David A Barrett, Kimberley D Bruce, Mitchell Sungelo, Robert H Eckel, Pavel Gershkovich. Eur J Pharm Sci 2017
100
Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects.
Naomi T Jessurun, Marjolein Drent, Eugène P van Puijenbroek, Otto Bekers, Petal A Wijnen, Aalt Bast. Curr Opin Pulm Med 2019
Naomi T Jessurun, Marjolein Drent, Eugène P van Puijenbroek, Otto Bekers, Petal A Wijnen, Aalt Bast. Curr Opin Pulm Med 2019
100
100
Translational insight into statin-induced muscle toxicity: from cell culture to clinical studies.
Dhiaa A Taha, Cornelia H De Moor, David A Barrett, Pavel Gershkovich. Transl Res 2014
Dhiaa A Taha, Cornelia H De Moor, David A Barrett, Pavel Gershkovich. Transl Res 2014
100
Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease.
Wim A Wuyts, Marlies Wijsenbeek, Benjamin Bondue, Demosthenes Bouros, Paul Bresser, Carlos Robalo Cordeiro, Ole Hilberg, Jesper Magnusson, Effrosyni D Manali, António Morais,[...]. Respiration 2020
Wim A Wuyts, Marlies Wijsenbeek, Benjamin Bondue, Demosthenes Bouros, Paul Bresser, Carlos Robalo Cordeiro, Ole Hilberg, Jesper Magnusson, Effrosyni D Manali, António Morais,[...]. Respiration 2020
100
Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.
Aurel C Allabi, Jean-Luc Gala, Jean-Pierre Desager, Michel Heusterspreute, Yves Horsmans. Br J Clin Pharmacol 2003
Aurel C Allabi, Jean-Luc Gala, Jean-Pierre Desager, Michel Heusterspreute, Yves Horsmans. Br J Clin Pharmacol 2003
100
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.
Eric Bruckert, Gilles Hayem, Sylvie Dejager, Caroline Yau, Bernard Bégaud. Cardiovasc Drugs Ther 2005
Eric Bruckert, Gilles Hayem, Sylvie Dejager, Caroline Yau, Bernard Bégaud. Cardiovasc Drugs Ther 2005
100
Interpretation of the evidence for the efficacy and safety of statin therapy.
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger Blumenthal, John Danesh, George Davey Smith, David DeMets,[...]. Lancet 2016
Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger Blumenthal, John Danesh, George Davey Smith, David DeMets,[...]. Lancet 2016
100
Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
Loredana Serpe, Roberto Canaparo, Maria Gabriella Scordo, Edoardo Spina. Drug Metab Pers Ther 2015
Loredana Serpe, Roberto Canaparo, Maria Gabriella Scordo, Edoardo Spina. Drug Metab Pers Ther 2015
100
Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.
Tim Walker, Joe McCaffery, Chris Steinfort. Med J Aust 2007
Tim Walker, Joe McCaffery, Chris Steinfort. Med J Aust 2007
100
Screening for Early Signs of Paternal Perinatal Affective Disorder in Expectant Fathers: A Cluster Analysis Approach.
Sonia Mangialavori, Michele Giannotti, Marco Cacioppo, Federico Spelzini, Franco Baldoni. J Pers Med 2020
Sonia Mangialavori, Michele Giannotti, Marco Cacioppo, Federico Spelzini, Franco Baldoni. J Pers Med 2020
100
SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Marja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi. Pharmacogenet Genomics 2006
Marja K Pasanen, Mikko Neuvonen, Pertti J Neuvonen, Mikko Niemi. Pharmacogenet Genomics 2006
100
The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers.
W J Tamminga, J Wemer, B Oosterhuis, R A de Zeeuw, L F de Leij, J H Jonkman. Eur J Clin Pharmacol 2001
W J Tamminga, J Wemer, B Oosterhuis, R A de Zeeuw, L F de Leij, J H Jonkman. Eur J Clin Pharmacol 2001
100
Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs.
D Wang, Y Guo, S A Wrighton, G E Cooke, W Sadee. Pharmacogenomics J 2011
D Wang, Y Guo, S A Wrighton, G E Cooke, W Sadee. Pharmacogenomics J 2011
100
Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach.
José V Castell, M Teresa Donato, María José Gómez-Lechón. Exp Toxicol Pathol 2005
José V Castell, M Teresa Donato, María José Gómez-Lechón. Exp Toxicol Pathol 2005
100
Statins: Adverse reactions, oxidative stress and metabolic interactions.
Aimei Liu, Qinghua Wu, Jingchao Guo, Irma Ares, José-Luis Rodríguez, María-Rosa Martínez-Larrañaga, Zonghui Yuan, Arturo Anadón, Xu Wang, María-Aránzazu Martínez. Pharmacol Ther 2019
Aimei Liu, Qinghua Wu, Jingchao Guo, Irma Ares, José-Luis Rodríguez, María-Rosa Martínez-Larrañaga, Zonghui Yuan, Arturo Anadón, Xu Wang, María-Aránzazu Martínez. Pharmacol Ther 2019
100
Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.
Takeshi Hirota, Hiroshi Takane, Shun Higuchi, Ichiro Ieiri. Curr Drug Metab 2008
Takeshi Hirota, Hiroshi Takane, Shun Higuchi, Ichiro Ieiri. Curr Drug Metab 2008
100
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
Joseph A Salami, Haider Warraich, Javier Valero-Elizondo, Erica S Spatz, Nihar R Desai, Jamal S Rana, Salim S Virani, Ron Blankstein, Amit Khera, Michael J Blaha,[...]. JAMA Cardiol 2017
Joseph A Salami, Haider Warraich, Javier Valero-Elizondo, Erica S Spatz, Nihar R Desai, Jamal S Rana, Salim S Virani, Ron Blankstein, Amit Khera, Michael J Blaha,[...]. JAMA Cardiol 2017
100
Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients.
Josephine H Li, Scott V Joy, Susanne B Haga, Lori A Orlando, William E Kraus, Geoffrey S Ginsburg, Deepak Voora. J Pers Med 2014
Josephine H Li, Scott V Joy, Susanne B Haga, Lori A Orlando, William E Kraus, Geoffrey S Ginsburg, Deepak Voora. J Pers Med 2014
100
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
David Williams, John Feely. Clin Pharmacokinet 2002
David Williams, John Feely. Clin Pharmacokinet 2002
100
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.
J Lazarou, B H Pomeranz, P N Corey. JAMA 1998
J Lazarou, B H Pomeranz, P N Corey. JAMA 1998
100
The role of acid-base imbalance in statin-induced myotoxicity.
Dhiaa A Taha, Cornelia H De Moor, David A Barrett, Jong Bong Lee, Raj D Gandhi, Chee Wei Hoo, Pavel Gershkovich. Transl Res 2016
Dhiaa A Taha, Cornelia H De Moor, David A Barrett, Jong Bong Lee, Raj D Gandhi, Chee Wei Hoo, Pavel Gershkovich. Transl Res 2016
100
Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatin.
A B Mulder, H J van Lijf, M A Bon, F A van den Bergh, D J Touw, C Neef, I Vermes. Clin Pharmacol Ther 2001
A B Mulder, H J van Lijf, M A Bon, F A van den Bergh, D J Touw, C Neef, I Vermes. Clin Pharmacol Ther 2001
100
Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy.
Philippe Couvert, Philippe Giral, Sylvie Dejager, Jessie Gu, Thierry Huby, M John Chapman, Eric Bruckert, Alain Carrié. Pharmacogenomics 2008
Philippe Couvert, Philippe Giral, Sylvie Dejager, Jessie Gu, Thierry Huby, M John Chapman, Eric Bruckert, Alain Carrié. Pharmacogenomics 2008
100
Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
Matthew Silva, Michele L Matthews, Courtney Jarvis, Nicole M Nolan, Paul Belliveau, Michael Malloy, Pritesh Gandhi. Clin Ther 2007
Matthew Silva, Michele L Matthews, Courtney Jarvis, Nicole M Nolan, Paul Belliveau, Michael Malloy, Pritesh Gandhi. Clin Ther 2007
100
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.
Jin-Fu Xu, George R Washko, Kiichi Nakahira, Hiroto Hatabu, Avignat S Patel, Isis E Fernandez, Mizuki Nishino, Yuka Okajima, Tsuneo Yamashiro, James C Ross,[...]. Am J Respir Crit Care Med 2012
Jin-Fu Xu, George R Washko, Kiichi Nakahira, Hiroto Hatabu, Avignat S Patel, Isis E Fernandez, Mizuki Nishino, Yuka Okajima, Tsuneo Yamashiro, James C Ross,[...]. Am J Respir Crit Care Med 2012
100
The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6.
Thomayant Prueksaritanont, Bennett Ma, Nathan Yu. Br J Clin Pharmacol 2003
Thomayant Prueksaritanont, Bennett Ma, Nathan Yu. Br J Clin Pharmacol 2003
100
Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10-hydroxynortriptyline serum levels-A prospective pharmacokinetic study.
Naomi T Jessurun, Annemieke Vermeulen Windsant, Oenone Mikes, Eugène P van Puijenbroek, Rob J van Marum, Koen Grootens, Hieronymus J Derijks. Br J Clin Pharmacol 2021
Naomi T Jessurun, Annemieke Vermeulen Windsant, Oenone Mikes, Eugène P van Puijenbroek, Rob J van Marum, Koen Grootens, Hieronymus J Derijks. Br J Clin Pharmacol 2021
100
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.
Eveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, Chin B Eap, Pierre Baumann. Drug Saf 2006
Eveline Jaquenoud Sirot, Jan Willem van der Velden, Katharina Rentsch, Chin B Eap, Pierre Baumann. Drug Saf 2006
100
Statin-associated muscle-related adverse effects: a case series of 354 patients.
Stephanie Cham, Marcella A Evans, Julie O Denenberg, Beatrice A Golomb. Pharmacotherapy 2010
Stephanie Cham, Marcella A Evans, Julie O Denenberg, Beatrice A Golomb. Pharmacotherapy 2010
100
A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
Keith B Hoffman, Christina Kraus, Mo Dimbil, Beatrice A Golomb. PLoS One 2012
Keith B Hoffman, Christina Kraus, Mo Dimbil, Beatrice A Golomb. PLoS One 2012
100
Drug-induced acid-base disorders.
Daniel Kitterer, Matthias Schwab, M Dominik Alscher, Niko Braun, Joerg Latus. Pediatr Nephrol 2015
Daniel Kitterer, Matthias Schwab, M Dominik Alscher, Niko Braun, Joerg Latus. Pediatr Nephrol 2015
100
Addressing phenoconversion: the Achilles' heel of personalized medicine.
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
Rashmi R Shah, Robert L Smith. Br J Clin Pharmacol 2015
100
Statin-induced fibrotic nonspecific interstitial pneumonia.
S Lantuejoul, E Brambilla, C Brambilla, G Devouassoux. Eur Respir J 2002
S Lantuejoul, E Brambilla, C Brambilla, G Devouassoux. Eur Respir J 2002
100
Statins and the risk of interstitial lung disease: a cohort study.
Nathalie Saad, Philippe Camus, Samy Suissa, Pierre Ernst. Thorax 2013
Nathalie Saad, Philippe Camus, Samy Suissa, Pierre Ernst. Thorax 2013
100
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.